Information displayed below is a subset of the entire knowledge base and may be incorrect, or incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.
Essential thrombocythemia (ET) is a rare type of blood cancer that affects the production of platelets in the bone marrow. It is a chronic disorder that causes the body to produce too many platelets, which can lead to an increased risk of blood clots. Symptoms of ET can include headaches, dizziness, fatigue, and shortness of breath. Treatment for ET typically involves medications to reduce the number of platelets in the blood, as well as lifestyle changes to reduce the risk of blood clots.
All of the following must be considered when interpreting clinical findings and are too extensive to be covered on this site: